Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 4 | 2022 | 84 | 2.460 |
Why?
|
| Familial Hypophosphatemic Rickets | 3 | 2023 | 4 | 2.410 |
Why?
|
| Bone Density | 14 | 2023 | 151 | 2.350 |
Why?
|
| HIV Infections | 6 | 2023 | 997 | 2.170 |
Why?
|
| Bone Matrix | 4 | 2017 | 28 | 2.100 |
Why?
|
| Bone and Bones | 9 | 2023 | 124 | 1.960 |
Why?
|
| Animals | 27 | 2023 | 4639 | 1.430 |
Why?
|
| Biomarkers | 8 | 2022 | 704 | 1.400 |
Why?
|
| Osteolysis | 5 | 2019 | 138 | 1.280 |
Why?
|
| X-Ray Microtomography | 10 | 2023 | 79 | 1.280 |
Why?
|
| Bone Remodeling | 4 | 2021 | 44 | 1.260 |
Why?
|
| Osteocalcin | 5 | 2022 | 23 | 1.240 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 12 | 1.230 |
Why?
|
| Parathyroid Hormone | 3 | 2021 | 24 | 1.190 |
Why?
|
| Glycoproteins | 3 | 2018 | 57 | 1.140 |
Why?
|
| Implants, Experimental | 3 | 2021 | 31 | 1.110 |
Why?
|
| Mice | 11 | 2023 | 1628 | 0.950 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 173 | 0.930 |
Why?
|
| Tooth | 1 | 2023 | 1 | 0.920 |
Why?
|
| Osseointegration | 3 | 2021 | 75 | 0.900 |
Why?
|
| Fractures, Bone | 2 | 2022 | 75 | 0.880 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2023 | 12 | 0.870 |
Why?
|
| Bone Development | 1 | 2023 | 37 | 0.850 |
Why?
|
| Joint Prosthesis | 2 | 2020 | 80 | 0.810 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 60 | 0.790 |
Why?
|
| Lactation | 2 | 2018 | 62 | 0.750 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 4 | 0.750 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 7 | 0.750 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 95 | 0.740 |
Why?
|
| Female | 16 | 2023 | 16426 | 0.720 |
Why?
|
| Bone Regeneration | 5 | 2021 | 75 | 0.650 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 8 | 0.650 |
Why?
|
| Weaning | 1 | 2018 | 5 | 0.650 |
Why?
|
| Minerals | 1 | 2018 | 5 | 0.650 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 463 | 0.650 |
Why?
|
| Male | 20 | 2023 | 15868 | 0.630 |
Why?
|
| Osteogenesis | 4 | 2021 | 103 | 0.610 |
Why?
|
| Titanium | 2 | 2021 | 197 | 0.610 |
Why?
|
| Rats | 10 | 2021 | 877 | 0.590 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 2 | 0.550 |
Why?
|
| Humans | 22 | 2023 | 29845 | 0.540 |
Why?
|
| Phosphates | 3 | 2021 | 21 | 0.530 |
Why?
|
| Mutation | 1 | 2016 | 399 | 0.470 |
Why?
|
| Antibodies | 1 | 2014 | 66 | 0.470 |
Why?
|
| Calcitonin | 1 | 2014 | 15 | 0.470 |
Why?
|
| Fracture Fixation | 1 | 2014 | 26 | 0.470 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 14 | 0.470 |
Why?
|
| Diphosphonates | 1 | 2014 | 16 | 0.470 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 12 | 0.460 |
Why?
|
| Absorptiometry, Photon | 3 | 2023 | 84 | 0.440 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 285 | 0.410 |
Why?
|
| Graft vs Host Disease | 2 | 2022 | 47 | 0.390 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 2005 | 0.380 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 2 | 2021 | 3 | 0.380 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 92 | 0.380 |
Why?
|
| Fibroblast Growth Factors | 2 | 2021 | 8 | 0.380 |
Why?
|
| Femur | 5 | 2021 | 393 | 0.360 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 857 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 78 | 0.350 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2023 | 19 | 0.350 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 32 | 0.340 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 969 | 0.340 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 256 | 0.340 |
Why?
|
| Prosthesis Failure | 3 | 2020 | 530 | 0.320 |
Why?
|
| Polyethyleneimine | 3 | 2015 | 6 | 0.290 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 9 | 0.270 |
Why?
|
| Arthroplasty, Replacement | 2 | 2020 | 149 | 0.270 |
Why?
|
| Skull | 2 | 2015 | 25 | 0.250 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 22 | 0.240 |
Why?
|
| Periodontal Ligament | 1 | 2023 | 1 | 0.230 |
Why?
|
| Calcium | 2 | 2018 | 498 | 0.230 |
Why?
|
| Biomechanical Phenomena | 3 | 2020 | 680 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 16 | 0.220 |
Why?
|
| Osteocytes | 2 | 2019 | 15 | 0.220 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 163 | 0.210 |
Why?
|
| Anti-Retroviral Agents | 1 | 2022 | 52 | 0.200 |
Why?
|
| Hypogonadism | 1 | 2021 | 7 | 0.200 |
Why?
|
| Infertility | 1 | 2021 | 7 | 0.200 |
Why?
|
| Emtricitabine | 1 | 2021 | 4 | 0.200 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 23 | 0.200 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 969 | 0.200 |
Why?
|
| Femur Neck | 1 | 2021 | 19 | 0.200 |
Why?
|
| Rats, Zucker | 1 | 2021 | 11 | 0.200 |
Why?
|
| Ovariectomy | 1 | 2021 | 28 | 0.190 |
Why?
|
| Collagen Type I | 1 | 2021 | 20 | 0.190 |
Why?
|
| Cartilage | 1 | 2022 | 154 | 0.190 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2021 | 8 | 0.190 |
Why?
|
| Azepines | 1 | 2021 | 7 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2021 | 22 | 0.190 |
Why?
|
| Chondrosarcoma | 1 | 2021 | 33 | 0.190 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 157 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 744 | 0.190 |
Why?
|
| Triazoles | 1 | 2021 | 33 | 0.190 |
Why?
|
| Plasmids | 3 | 2015 | 44 | 0.190 |
Why?
|
| Adipose Tissue | 1 | 2021 | 74 | 0.180 |
Why?
|
| Viral Load | 1 | 2021 | 208 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2021 | 166 | 0.180 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 106 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 532 | 0.170 |
Why?
|
| HIV-1 | 1 | 2023 | 451 | 0.170 |
Why?
|
| Body Weight | 1 | 2019 | 132 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2017 | 77 | 0.170 |
Why?
|
| Collagen | 2 | 2016 | 102 | 0.160 |
Why?
|
| Porosity | 1 | 2018 | 69 | 0.160 |
Why?
|
| Hyperostosis | 1 | 2018 | 1 | 0.160 |
Why?
|
| Syndactyly | 1 | 2018 | 2 | 0.160 |
Why?
|
| Anabolic Agents | 1 | 2018 | 6 | 0.160 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 1270 | 0.160 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 103 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 142 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2018 | 522 | 0.150 |
Why?
|
| Pregnancy | 1 | 2018 | 387 | 0.150 |
Why?
|
| Cortical Bone | 1 | 2017 | 7 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 36 | 0.140 |
Why?
|
| Prevalence | 1 | 2018 | 494 | 0.140 |
Why?
|
| Comorbidity | 1 | 2018 | 504 | 0.140 |
Why?
|
| X-Rays | 1 | 2016 | 4 | 0.140 |
Why?
|
| Point Mutation | 1 | 2016 | 30 | 0.140 |
Why?
|
| Radiography | 1 | 2018 | 678 | 0.130 |
Why?
|
| Middle Aged | 2 | 2021 | 9960 | 0.130 |
Why?
|
| Independent Living | 1 | 2018 | 285 | 0.130 |
Why?
|
| Prognosis | 1 | 2018 | 874 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2018 | 685 | 0.130 |
Why?
|
| RNA | 1 | 2015 | 40 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2016 | 299 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 46 | 0.130 |
Why?
|
| Phenotype | 1 | 2016 | 364 | 0.120 |
Why?
|
| Genotype | 1 | 2016 | 408 | 0.120 |
Why?
|
| Copper | 1 | 2014 | 12 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2015 | 309 | 0.120 |
Why?
|
| Chitosan | 1 | 2014 | 5 | 0.120 |
Why?
|
| Aged | 2 | 2018 | 9619 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 69 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 435 | 0.120 |
Why?
|
| Diaphyses | 1 | 2014 | 4 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 40 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 18 | 0.120 |
Why?
|
| Microvessels | 1 | 2014 | 16 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 26 | 0.120 |
Why?
|
| Fracture Healing | 1 | 2014 | 41 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2014 | 49 | 0.120 |
Why?
|
| Adult | 3 | 2022 | 8746 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 89 | 0.120 |
Why?
|
| Cognition | 1 | 2022 | 1314 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1126 | 0.120 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 24 | 0.120 |
Why?
|
| Thiophenes | 1 | 2014 | 13 | 0.120 |
Why?
|
| Joints | 1 | 2014 | 99 | 0.120 |
Why?
|
| Models, Animal | 1 | 2014 | 128 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 90 | 0.120 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 6 | 0.120 |
Why?
|
| Corpus Striatum | 1 | 2014 | 113 | 0.120 |
Why?
|
| Methamphetamine | 1 | 2014 | 48 | 0.120 |
Why?
|
| Bone Resorption | 1 | 2014 | 95 | 0.110 |
Why?
|
| Humerus | 1 | 2014 | 101 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 379 | 0.110 |
Why?
|
| Tibia | 1 | 2014 | 266 | 0.100 |
Why?
|
| Bone Marrow | 2 | 2022 | 78 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 803 | 0.100 |
Why?
|
| Rats, Inbred F344 | 3 | 2015 | 48 | 0.090 |
Why?
|
| DNA | 3 | 2015 | 123 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4930 | 0.080 |
Why?
|
| Calcification, Physiologic | 2 | 2019 | 21 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 490 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 266 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2021 | 206 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 677 | 0.070 |
Why?
|
| Cell Survival | 2 | 2015 | 165 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2015 | 91 | 0.060 |
Why?
|
| Lamivudine | 1 | 2023 | 20 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 98 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 57 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2022 | 23 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2021 | 35 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 42 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2021 | 18 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 25 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 36 | 0.050 |
Why?
|
| Proteins | 1 | 2021 | 71 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 273 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 133 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 129 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1462 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 812 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 119 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 2 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 58 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 28 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3560 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 103 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2018 | 174 | 0.040 |
Why?
|
| Spine | 1 | 2018 | 123 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 372 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 18 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 11 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 58 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 36 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 9 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 16 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 24 | 0.030 |
Why?
|
| Self Administration | 1 | 2014 | 36 | 0.030 |
Why?
|
| Corrosion | 1 | 2014 | 129 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 169 | 0.030 |
Why?
|
| Hypoxia | 1 | 2014 | 63 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 103 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 130 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 63 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 116 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 403 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 232 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 494 | 0.030 |
Why?
|
| Risk Factors | 1 | 2014 | 2466 | 0.020 |
Why?
|